Aká srdcová frekvencia je riziková v rôznych štádiách kardiovaskulárneho kontinua?
[What is a risk heart rate at various stages of the cardiovascular continuum?]
Jazyk čeština Země Česko Médium print
Typ dokumentu časopisecké články
PubMed
36316200
DOI
10.36290/vnl.2022.079
PII: 132375
- Klíčová slova
- arterial hypertension, fixed drug combinations, heart rate, treatment adherence,
- MeSH
- adherence k farmakoterapii MeSH
- antihypertenziva terapeutické užití MeSH
- hypertenze * komplikace farmakoterapie MeSH
- kardiovaskulární nemoci * prevence a kontrola chemicky indukované MeSH
- krevní tlak MeSH
- lidé MeSH
- srdeční frekvence MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- antihypertenziva MeSH
Prevention, detection, and treatment of high blood pressure remain an important public health challenge. There is convincing evidence that heart rate is an important risk factor for cardiovascular disease. Recommendations for the resting heart rate measurement are roughly the same as those used for blood pressure measurement which is usually made during the same session. Across different parts of the cardiovascular disease continuum, different heart rate thresholds are identified. Elevated heart rate identifies patients with hypertension at high cardiovascular risk. One of the important causes of inadequate blood pressure control and at the same time heart rate control is the poor adherence of patients to treatment. It is necessary to individualize the treatment of patients with elevated heart rates throughout the cardiovascular continuum. Fixed-dose combination decreases the risk of medication non-compliance and should be considered in patients with chronic conditions like hypertension for improving medication compliance which can translate into better clinical outcomes.
Citace poskytuje Crossref.org